|
|
|
Volumn 17, Issue 4, 2002, Pages 175-176
|
|
Neuroprotection: Promise and pitfalls in anti-inflammatory treatment of Alzheimer's disease
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
AMYLOID BETA PROTEIN;
ANTIINFLAMMATORY AGENT;
BENZODIAZEPINE;
BIOLOGICAL MARKER;
CELECOXIB;
CHOLINESTERASE INHIBITOR;
CORTICOSTEROID;
CYCLOOXYGENASE 1 INHIBITOR;
CYCLOOXYGENASE 2 INHIBITOR;
CYTOKINE;
GLUTAMIC ACID;
NAPROXEN;
NONSTEROID ANTIINFLAMMATORY AGENT;
PROSTAGLANDIN SYNTHASE;
STEROID;
ALZHEIMER DISEASE;
AUTOPSY;
BRAIN SCINTISCANNING;
CARDIOVASCULAR DISEASE;
CELL DAMAGE;
CELL LOSS;
CINGULATE GYRUS;
CLINICAL TRIAL;
COGNITION;
COGNITIVE DEFECT;
DISEASE COURSE;
DISEASE SEVERITY;
DRUG EFFECT;
DRUG EFFICACY;
DRUG MECHANISM;
EDITORIAL;
ELDERLY CARE;
ENTORHINAL CORTEX;
ENZYME ACTIVITY;
ENZYME INHIBITION;
EPIDEMIOLOGICAL DATA;
HEALTH CARE COST;
HIGH RISK POPULATION;
HUMAN;
IMMUNE RESPONSE;
IN VIVO STUDY;
LOW DRUG DOSE;
MICROGLIA;
NERVE DEGENERATION;
NEUROFIBRILLARY TANGLE;
NEUROPROTECTION;
OUTCOMES RESEARCH;
PARIETAL LOBE;
PATHOGENESIS;
PRIMARY PREVENTION;
PROPHYLAXIS;
PROSPECTIVE STUDY;
RECEPTOR BINDING;
RISK;
SWEDEN;
TEMPORAL CORTEX;
THROMBOCYTE AGGREGATION INHIBITION;
UNITED STATES;
AGED;
ALZHEIMER DISEASE;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
BIOLOGICAL MARKERS;
CLINICAL TRIALS;
DISEASE PROGRESSION;
HUMANS;
NEUROPROTECTIVE AGENTS;
|
|
EID: 0036821237
PISSN: 03935264
EISSN: None
Source Type: Journal
DOI: None Document Type: Editorial |
|
Times cited : (1)
|
|
References (0)
|